Peripheral T-lymphocyte subpopulations in different clinical stages of chronic HBV infection correlate with HBV load

被引:71
作者
You, Jing [1 ]
Zhuang, Lin [2 ]
Zhang, Yi-Feng [1 ]
Chen, Hong-Ying [1 ]
Sriplung, Hutcha [3 ]
Geater, Alan [3 ]
Chongsuvivatwong, Virasakdi [3 ]
Piratvisuth, Teerha [5 ]
McNeil, Edward [3 ]
Yu, Lan [1 ]
Tang, Bao-Zhang [1 ]
Huang, Jun-Hua [4 ]
机构
[1] Kunming Med Univ, Affiliated Hosp 1, Dept Infect Dis, Kunming 650032, Yunnan Province, Peoples R China
[2] Third Kunming Peoples Hosp, Dept Hepatol, Kunming 650041, Yunnan Province, Peoples R China
[3] Prince Songkla Univ, Fac Med, Epidemiol Unit, Hat Yai 90110, Songkhla, Thailand
[4] Yunnan Gen Hosp, Chinese Peoples Armed Police Forces, Dept Infect Dis, Kunming 650111, Yunnan Province, Peoples R China
[5] Prince Songkla Univ, Fac Med, NKC Inst Gastroenterol & Hepatol, Hat Yai 90110, Songkhla, Thailand
关键词
Hepatitis B virus; Chronic hepatitis B virus infection; Clinical stages; Hepatitis B virus DNA; T lymphocyte subpopulation; HEPATITIS-B-VIRUS; RECEPTOR TRANSGENIC MICE; BLOOD MONONUCLEAR-CELLS; CHRONIC VIRAL-INFECTION; C VIRUS; IMMUNE-RESPONSE; CORE ANTIGEN; INTRAHEPATIC LYMPHOCYTES; LAMIVUDINE TREATMENT; NATURAL-HISTORY;
D O I
10.3748/wjg.15.3382
中图分类号
R57 [消化系及腹部疾病];
学科分类号
100201 [内科学];
摘要
AIM: To characterize the peripheral T-cell subpopulation profiles and their correlation with hepatitis B virus (HBV) replication in different clinical stages of chronic HBV infection. METHODS: A total of 422 patients with chronic HBV infection were enrolled in this study. The patients were divided into three stages: immune-tolerant stage, immune active stage, and immune-inactive carrier stage. Composition of peripheral T-cell subpopulations was determined by flow cytometry. HBV markers were detected by enzyme-linked immunosorbent assay. Serum HBV DNA load was assessed by quantitative real-time polymerase chain reaction. RESULTS: CD8(+) T-cells were significantly higher in patients at the immune-tolerant stage than in patients at the immune-active and -inactive carrier stages (36.87 +/- 7.58 vs 34.37 +/- 9.07, 36.87 +/- 7.58 vs 28.09 +/- 5.64, P < 0.001). The peripheral blood in patients at the immune-tolerant and immune active stages contained more CD8(+) T-cells than CD4(+) T-cells (36.87 7.58 vs 30.23 +/- 6.35, 34.37 +/- 9.07 vs 30.92 +/- 7.40, P < 0.01), whereas the peripheral blood in patients at the immuneinactive carrier stage and in normal controls contained less CD8(+) T-cells than CD4(+) T-cells (28.09 +/- 5.64 vs 36.85 +/- 6.06, 24.02 +/- 4.35 vs 38.94 +/- 3.39, P < 0.01). ANOVA linear trend test showed that CD8(+) T-cells were significantly increased in patients with a high viral load (39.41 +/- 7.36, 33.83 +/- 7.50, 31.81 +/- 5.95 and 26.89 +/- 5.71, P < 0.001), while CD4(+) T-cells were significantly increased in patients with a low HBV DNA load (37.45 +/- 6.14, 33.33 +/- 5.61, 31.58 +/- 6.99 and 27.56 +/- 5.49, P < 0.001). Multiple regression analysis displayed that log copies of HBV DNA still maintained its highly significant coefficients for T-cell subpopulations, and was the strongest predictors for variations in CD3(+), CD4(+) and CD8(+) cells and CD4(+)/CD8(+) ratio after adjustment for age at HBV-infection, maternal HBV-infection status, presence of hepatitis B e antigen and HBV mutation. CONCLUSION: Differences in peripheral T-cell subpopulation profiles can be found in different clinical stages of chronic HBV infection. T-cell impairment is significantly associated with HBV load.
引用
收藏
页码:3382 / 3393
页数:12
相关论文
共 72 条
[1]
ALEXANDER GJM, 1986, CLIN EXP IMMUNOL, V63, P498
[2]
[Anonymous], R LANG ENV STAT COMP
[3]
Pathogenesis of hepatitis B virus infection [J].
Baumert, Thomas F. ;
Thimme, Robert ;
von Weizsaecker, Fritz .
WORLD JOURNAL OF GASTROENTEROLOGY, 2007, 13 (01) :82-90
[4]
HEPATITIS-B ANTIGENS IN SERUM AND LIVER OF CHIMPANZEES ACUTELY INFECTED WITH HEPATITIS-B VIRUS [J].
BERQUIST, KR ;
PETERSON, JM ;
MURPHY, BL ;
EBERT, JW ;
MAYNARD, JE ;
PURCELL, RH .
INFECTION AND IMMUNITY, 1975, 12 (03) :602-605
[5]
CYTOTOXIC T-LYMPHOCYTE RESPONSE TO A WILD-TYPE HEPATITIS-B VIRUS EPITOPE IN PATIENTS CHRONICALLY INFECTED BY VARIANT VIRUSES CARRYING SUBSTITUTIONS WITHIN THE EPITOPE [J].
BERTOLETTI, A ;
COSTANZO, A ;
CHISARI, FV ;
LEVRERO, M ;
ARTINI, M ;
SETTE, A ;
PENNA, A ;
GIUBERTI, T ;
FIACCADORI, F ;
FERRARI, C .
JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 180 (03) :933-943
[6]
NATURAL VARIANTS OF CYTOTOXIC EPITOPES ARE T-CELL RECEPTOR ANTAGONISTS FOR ANTIVIRAL CYTOTOXIC T-CELLS [J].
BERTOLETTI, A ;
SETTE, A ;
CHISARI, FV ;
PENNA, A ;
LEVRERO, M ;
DECARLI, M ;
FIACCADORI, F ;
FERRARI, C .
NATURE, 1994, 369 (6479) :407-410
[7]
The immune response during hepatitis B virus infection [J].
Bertoletti, Antonio ;
Gehring, Adam J. .
JOURNAL OF GENERAL VIROLOGY, 2006, 87 :1439-1449
[8]
Lamivudine treatment can overcome cytotoxic T-cell hyporesponsiveness in chronic hepatitis B: New perspectives for immune therapy [J].
Boni, C ;
Penna, A ;
Ogg, GS ;
Bertoletti, A ;
Pilli, M ;
Cavallo, C ;
Cavalli, A ;
Urbani, S ;
Boehme, R ;
Panebianco, R ;
Fiaccadori, F ;
Ferrari, C .
HEPATOLOGY, 2001, 33 (04) :963-971
[9]
Lamivudine treatment can restore T cell responsiveness in chronic hepatitis B [J].
Boni, C ;
Bertoletti, A ;
Penna, A ;
Cavalli, A ;
Pilli, M ;
Urbani, S ;
Scognamiglio, P ;
Boehme, R ;
Panebianco, R ;
Fiaccadori, F ;
Ferrari, C .
JOURNAL OF CLINICAL INVESTIGATION, 1998, 102 (05) :968-975
[10]
Transient restoration of anti-viral T cell responses induced by lamivudine therapy in chronic hepatitis B [J].
Boni, C ;
Penna, A ;
Bertoletti, A ;
Lamonaca, V ;
Rapti, I ;
Missale, G ;
Pilli, M ;
Urbani, S ;
Cavalli, A ;
Cerioni, S ;
Panebianco, R ;
Jenkins, J ;
Ferrari, C .
JOURNAL OF HEPATOLOGY, 2003, 39 (04) :595-605